Büll et al. observed increased clustering between desialylated melanoma cells and CD8+ T cells with a transgenic T-cell receptor compared to control cells [12], suggesting that the SA blockade facilitates tumor cell–T cell interactions. The gene discussed is CD8A; the disease is neoplasm.